与长期戊聚糖多硫酸盐治疗相关的黄斑病变患病率 - Suppr

Suppr

超能文献

Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy.

作者信息

Vora Robin A, Patel Amar P, Melles Ronald

机构信息

Kaiser Permanente Northern California, Oakland, California.

出版信息

Ophthalmology. 2020 Jun;127(6):835-836. doi: 10.1016/j.ophtha.2020.01.017. Epub 2020 Jan 17.

DOI:10.1016/j.ophtha.2020.01.017

PMID:32085877

Abstract

摘要

相似文献

Prevalence of Maculopathy Associated with Long-Term Pentosan Polysulfate Therapy.

Ophthalmology. 2020 Jun;127(6):835-836. doi: 10.1016/j.ophtha.2020.01.017. Epub 2020 Jan 17.

Pentosan Polysulfate Maculopathy: What Urologists Should Know in 2020.

Urology. 2021 Jan;147:109-118. doi: 10.1016/j.urology.2020.08.072. Epub 2020 Oct 10.

Ocular Toxicity Associated With Pentosan Polysulfate Sodium.

Mayo Clin Proc. 2021 Jun;96(6):1682-1684. doi: 10.1016/j.mayocp.2021.04.002.

Maculopathy caused by pentosan polysulfate.

CMAJ. 2021 May 3;193(18):E645. doi: 10.1503/cmaj.201900.

Pentosan Polysulfate-Associated Macular Disease in Patients With Interstitial Cystitis.

Obstet Gynecol. 2020 May;135(5):1091-1094. doi: 10.1097/AOG.0000000000003794.

Strength of Association between Pentosan Polysulfate and a Novel Maculopathy.

Ophthalmology. 2019 Oct;126(10):1464-1466. doi: 10.1016/j.ophtha.2019.04.024. Epub 2019 Apr 18.

Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis.

Can J Ophthalmol. 2020 Apr;55(2):116-125. doi: 10.1016/j.jcjo.2019.12.001. Epub 2020 Jan 20.

Asia Pac J Ophthalmol (Phila). 2022;11(2):100-110. doi: 10.1097/APO.0000000000000504.

Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States.

Ophthalmology. 2020 Apr;127(4):535-543. doi: 10.1016/j.ophtha.2019.10.036. Epub 2019 Nov 5.

Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.

Can J Ophthalmol. 2022 Feb;57(1):16-22. doi: 10.1016/j.jcjo.2021.02.007. Epub 2021 Mar 12.

引用本文的文献

Evaluating for pentosan polysulfate maculopathy at a single academic institution.

Ther Adv Ophthalmol. 2025 Aug 11;17:25158414251364944. doi: 10.1177/25158414251364944. eCollection 2025 Jan-Dec.

2025 Canadian Urological Association Guideline: Selected treatment recommendations for interstitial cystitis/bladder pain syndrome.

Can Urol Assoc J. 2025 Apr;19(4):90-103. doi: 10.5489/cuaj.9182.

Retrospective study of incidence/prevalence of pigmentary maculopathy and retinopathy in patients receiving pentosan polysulfate sodium.

PLoS One. 2025 Jan 9;20(1):e0313497. doi: 10.1371/journal.pone.0313497. eCollection 2025.

Systemic Medications and Their Ocular Side Effects.

Cureus. 2024 Dec 2;16(12):e74976. doi: 10.7759/cureus.74976. eCollection 2024 Dec.

Advanced pentosan polysulfate sodium maculopathy with low cumulative exposure and hydroxychloroquine use.

Am J Ophthalmol Case Rep. 2024 Nov 22;36:102224. doi: 10.1016/j.ajoc.2024.102224. eCollection 2024 Dec.

Mimickers of hydroxychloroquine retinal toxicity.

Clin Exp Ophthalmol. 2024 Dec;52(9):1003-1015. doi: 10.1111/ceo.14461. Epub 2024 Dec 3.

Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.

J Vitreoretin Dis. 2024 Aug 22;8(5):500-507. doi: 10.1177/24741264241261441. eCollection 2024 Sep-Oct.

Real-World Practices of Pentosan Polysulfate Maculopathy Screening in Various Clinical Settings and Practice-Associated Factors.

J Clin Med. 2024 Aug 27;13(17):5090. doi: 10.3390/jcm13175090.

Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging.

J Vitreoretin Dis. 2024 Jan 31;8(3):325-333. doi: 10.1177/24741264241228375. eCollection 2024 May-Jun.

Screening practices and risk assessment for maculopathy in pentosan polysulfate users across different exposure levels.

Sci Rep. 2024 May 17;14(1):11270. doi: 10.1038/s41598-024-62041-y.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验